Stefan Ambs

National Institutes of Health

Full Professor(heuristic)

Cancer-related molecular mechanisms research · Cancer Research

h-index71

i10-index157

Publications638

Citations21,914

Grants

50 total · 0 active

NIH #1ZIABC010624-22

The Molecular Profile of Prostate Tumors in African-American Men

Amount: $541K
Period: — → —
PIs: 1
Est. capacity / PI: ~9 students

Awarded at DIVISION OF BASIC SCIENCES - NCI

NIH #1ZIABC010499-23

Maryland Prostate Cancer Case-Control Study

Amount: $541K
Period: — → —
PIs: 1
Est. capacity / PI: ~9 students

Awarded at DIVISION OF BASIC SCIENCES - NCI

NIH #1ZIABC010887-18

Novel Markers for Disease Outcome in Breast Cancer

Amount: $721K
Period: — → —
PIs: 1
Est. capacity / PI: ~12 students

Awarded at DIVISION OF BASIC SCIENCES - NCI

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 94

Urinary Creatine Riboside Complements PSA to Improve Disease Detection in the Diagnostic Gray Zone of Prostate Cancer
medRxiv · 2026-06-18
Supplementary Data from Case-Case Genome-Wide Analyses Identify Subtype-Informative Variants That Confer Risk for Breast Cancer
2026-06-17
Urinary creatine riboside for risk stratification of clinically significant prostate cancer.
Journal of Clinical Oncology · 2026-05-28
Diversity, equity, and inclusion as scientific rigor: progress during challenging times
JNCI Cancer Spectrum · 2026-05-01
NOS2 and COX2 impact the spatial landscape of CD8+ T cells in ER-breast cancer, providing novel mechanistic insight that drives tumor progression and poor survival
Redox Biology · 2026-04-27
Abstract 7606: Tumor and Host Determinants of the Breast Tumor Immune Microenvironment in Kenyan Breast Cancer Women.
Cancer Research · 2026-04-03
p53-induced RNA-binding protein ZMAT3 inhibits transcription of a hexokinase to suppress mitochondrial respiration in human cancer cells
eLife · 2026-03-17
Supplementary Figure 6 from Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER− Breast Cancer
2026-03-16
Supplementary Table I from Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER− Breast Cancer
2026-03-16
Supplementary Figure 4 from Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER− Breast Cancer
2026-03-16
Supplementary Table II from Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER− Breast Cancer
2026-03-16
Supplementary Figure 1 from Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER− Breast Cancer
2026-03-16
Supplementary Figure 3 from Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER− Breast Cancer
2026-03-16
Supplementary Figure 5 from Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER− Breast Cancer
2026-03-16
Supplementary Figure 2 from Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER− Breast Cancer
2026-03-16
Diversity, equity, and inclusion as scientific rigor: progress during challenging times
JNCI Journal of the National Cancer Institute · 2026-03-03
Abstract 61: Optimizing Breast Cancer Subtyping in Kenya: Concordance Between Immunohistochemistry and PAM50 Molecular Classification and Strategies for Resource-Limited Settings
Cancer Epidemiology Biomarkers & Prevention · 2025-12-01
1111 Single-cell-driven design of logic-gated CAR circuits for enhanced solid tumor immunotherapy
Regular and Young Investigator Award Abstracts · 2025-11-01
Abstract C042: Systematic discovery of logic-gated cell surface targets for enhanced solid tumor CAR therapy through single-cell transcriptomics
Molecular Cancer Therapeutics · 2025-10-22
Abstract C039: Evaluation of allostatic load and urinary surrogate markers as biomarkers of stress in prostate cancer patients
Cancer Epidemiology Biomarkers & Prevention · 2025-09-18

Open author page on OpenAlex →